MAI Capital Management
KMTS icon

MAI Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

MAI Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-772
Closed -$15.4K – 4993
2026
Q1 		$15.4K Buy
772
+7
+0.9% +$165 ﹤0.01% 2932
2025
Q4 		$20.3K Hold
765
– – ﹤0.01% 2506
2025
Q3 		$18.2K Buy
+765
New +$13.7K ﹤0.01% 2445

Other funds holding KMTS

Bain Capital Investors
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

MAI Capital Management's KMTS Position: Q2 2026 in Review

MAI Capital Management sold out of Kestra Medical Technologies (KMTS) in Q2 2026, closing a stake of 772 shares — an estimated $15.4K sold.

MAI Capital Management first reported a position in KMTS in Q3 2025 and held it in 3 quarters. The position peaked at $20.3K in Q4 2025. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • MAI Capital Management reported no remaining Kestra Medical Technologies position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 772 Kestra Medical Technologies shares in Q2 2026, an estimated $15.4K.
  • MAI Capital Management first reported a position in Kestra Medical Technologies in Q3 2025 and held it in 3 quarters.
  • MAI Capital Management's Kestra Medical Technologies position peaked at $20.3K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.